Owens & Minor (OMI) Competitors

$18.62
-0.49 (-2.56%)
(As of 05/17/2024 ET)

OMI vs. PDCO, NHC, ATEC, NMRA, LGND, WRBY, INMD, AVDL, RCUS, and SLNO

Should you be buying Owens & Minor stock or one of its competitors? The main competitors of Owens & Minor include Patterson Companies (PDCO), National HealthCare (NHC), Alphatec (ATEC), Neumora Therapeutics (NMRA), Ligand Pharmaceuticals (LGND), Warby Parker (WRBY), InMode (INMD), Avadel Pharmaceuticals (AVDL), Arcus Biosciences (RCUS), and Soleno Therapeutics (SLNO). These companies are all part of the "medical" sector.

Owens & Minor vs.

Patterson Companies (NASDAQ:PDCO) and Owens & Minor (NYSE:OMI) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings, community ranking and risk.

Patterson Companies has a net margin of 2.95% compared to Patterson Companies' net margin of -0.37%. Owens & Minor's return on equity of 20.98% beat Patterson Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Patterson Companies2.95% 20.98% 7.70%
Owens & Minor -0.37%12.97%2.26%

85.4% of Patterson Companies shares are owned by institutional investors. Comparatively, 98.0% of Owens & Minor shares are owned by institutional investors. 1.5% of Patterson Companies shares are owned by insiders. Comparatively, 3.6% of Owens & Minor shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Patterson Companies has a beta of 1.07, suggesting that its stock price is 7% more volatile than the S&P 500. Comparatively, Owens & Minor has a beta of 0.52, suggesting that its stock price is 48% less volatile than the S&P 500.

In the previous week, Patterson Companies and Patterson Companies both had 8 articles in the media. Patterson Companies' average media sentiment score of 0.22 beat Owens & Minor's score of 0.01 indicating that Owens & Minor is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Patterson Companies
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral
Owens & Minor
1 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Patterson Companies received 110 more outperform votes than Owens & Minor when rated by MarketBeat users. Likewise, 52.48% of users gave Patterson Companies an outperform vote while only 48.64% of users gave Owens & Minor an outperform vote.

CompanyUnderperformOutperform
Patterson CompaniesOutperform Votes
360
52.48%
Underperform Votes
326
47.52%
Owens & MinorOutperform Votes
250
48.64%
Underperform Votes
264
51.36%

Patterson Companies has higher earnings, but lower revenue than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than Patterson Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Patterson Companies$6.47B0.36$207.56M$2.0312.69
Owens & Minor$10.33B0.14-$41.30M-$0.51-36.51

Patterson Companies presently has a consensus price target of $32.56, suggesting a potential upside of 26.38%. Owens & Minor has a consensus price target of $23.29, suggesting a potential upside of 25.06%. Given Owens & Minor's stronger consensus rating and higher probable upside, equities research analysts clearly believe Patterson Companies is more favorable than Owens & Minor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Patterson Companies
0 Sell rating(s)
6 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Owens & Minor
1 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Patterson Companies beats Owens & Minor on 13 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OMI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OMI vs. The Competition

MetricOwens & MinorMedical & hospital equipment IndustryMedical SectorNYSE Exchange
Market Cap$1.42B$7.85B$5.24B$18.08B
Dividend YieldN/A2.33%44.56%3.44%
P/E Ratio-36.5119.05139.1326.21
Price / Sales0.141.172,371.9310.64
Price / Cash3.6311.1836.9819.24
Price / Book1.592.325.516.00
Net Income-$41.30M$249.27M$106.02M$966.17M
7 Day Performance-0.05%1.71%1.42%1.85%
1 Month Performance-24.87%-3.66%4.97%6.59%
1 Year Performance-8.19%0.06%7.93%23.69%

Owens & Minor Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PDCO
Patterson Companies
4.7632 of 5 stars
$25.44
-0.5%
$32.56
+28.0%
-5.6%$2.28B$6.47B12.537,600
NHC
National HealthCare
0 of 5 stars
$98.03
+1.1%
N/AN/A$1.51B$1.14B18.6413,123Earnings Report
Dividend Increase
ATEC
Alphatec
4.2553 of 5 stars
$10.87
-2.4%
$22.89
+110.6%
-27.9%$1.52B$482.26M-7.30839
NMRA
Neumora Therapeutics
0.5457 of 5 stars
$9.58
+6.9%
$22.57
+135.6%
N/A$1.53BN/A0.00124
LGND
Ligand Pharmaceuticals
4.9131 of 5 stars
$85.29
+1.5%
$116.33
+36.4%
+11.9%$1.54B$131.31M16.5058Insider Selling
News Coverage
WRBY
Warby Parker
0.7941 of 5 stars
$15.56
+0.3%
$16.50
+6.1%
+39.6%$1.54B$669.77M-33.103,491Gap Up
INMD
InMode
2.89 of 5 stars
$18.58
+0.5%
$32.80
+76.5%
-44.4%$1.56B$492.05M8.81581Short Interest ↑
News Coverage
AVDL
Avadel Pharmaceuticals
3.8244 of 5 stars
$16.12
-4.1%
$24.17
+49.9%
+13.2%$1.46B$27.96M-8.67154
RCUS
Arcus Biosciences
1.275 of 5 stars
$17.10
-0.6%
$41.25
+141.2%
-4.0%$1.57B$237M-5.50577Gap Up
SLNO
Soleno Therapeutics
3.9641 of 5 stars
$43.50
+1.6%
$60.33
+38.7%
+955.1%$1.45BN/A-16.2333

Related Companies and Tools

This page (NYSE:OMI) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners